Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiling Lu

Showing results (141-150 of 224) with videos related to

Pageof 23
Sort By:
Journal of Cellular Biochemistry|July 20, 2004
Lysophosphatidic acid production and action: validated targets in cancer?Makiko Umezu-Goto, Janos Tanyi, John Lahad, et al.
BMC Cancer|February 25, 2014
A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylationKimberly C Wiegand, Bryan T Hennessy, Samuel Leung, et al.
Cancer Cell|May 30, 2009
Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastasesShuying Liu, Makiko Umezu-Goto, Mandi Murph, et al.
Genome Research|April 16, 2017
Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancersYumeng Wang, Xiaoyan Xu, Shuangxing Yu, et al.
Cell Reports|May 11, 2016
Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian CancerPradeep Chaluvally-Raghavan, Kang Jin Jeong, Sunila Pradeep, et al.
Gynecologic Oncology|February 15, 2003
Specific keynote: molecular therapeutics in ovarian cancerGordon B Mills, Xianjun Fang, Yiling Lu, et al.
Genome Research|November 8, 2014
Cupid: simultaneous reconstruction of microRNA-target and ceRNA networksHua-Sheng Chiu, David Llobet-Navas, Xuerui Yang, et al.
Molecular Cancer Therapeutics|October 14, 2011
Dual inhibition of tumor energy pathway by 2-deoxyglucose and metformin is effective against a broad spectrum of preclinical cancer modelsJae-Ho Cheong, Eun Sung Park, Jiyong Liang, et al.
BMC Cancer|July 18, 2018
AKT isoform-specific expression and activation across cancer lineagesJue Wang, Wei Zhao, Huifang Guo, et al.
The Journal of Experimental Medicine|November 26, 2021
WEE1 inhibition induces anti-tumor immunity by activating ERV and the dsRNA pathwayEnsong Guo, Rourou Xiao, Yifan Wu, et al.
Pageof 23

Showing results (141-150 of 224) with videos related to

Sort By:
Pageof 23
Journal of Cellular Biochemistry|July 20, 2004
Lysophosphatidic acid production and action: validated targets in cancer?Makiko Umezu-Goto, Janos Tanyi, John Lahad, et al.
BMC Cancer|February 25, 2014
A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylationKimberly C Wiegand, Bryan T Hennessy, Samuel Leung, et al.
Cancer Cell|May 30, 2009
Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastasesShuying Liu, Makiko Umezu-Goto, Mandi Murph, et al.
Genome Research|April 16, 2017
Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancersYumeng Wang, Xiaoyan Xu, Shuangxing Yu, et al.
Cell Reports|May 11, 2016
Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian CancerPradeep Chaluvally-Raghavan, Kang Jin Jeong, Sunila Pradeep, et al.
Gynecologic Oncology|February 15, 2003
Specific keynote: molecular therapeutics in ovarian cancerGordon B Mills, Xianjun Fang, Yiling Lu, et al.
Genome Research|November 8, 2014
Cupid: simultaneous reconstruction of microRNA-target and ceRNA networksHua-Sheng Chiu, David Llobet-Navas, Xuerui Yang, et al.
Molecular Cancer Therapeutics|October 14, 2011
Dual inhibition of tumor energy pathway by 2-deoxyglucose and metformin is effective against a broad spectrum of preclinical cancer modelsJae-Ho Cheong, Eun Sung Park, Jiyong Liang, et al.
BMC Cancer|July 18, 2018
AKT isoform-specific expression and activation across cancer lineagesJue Wang, Wei Zhao, Huifang Guo, et al.
The Journal of Experimental Medicine|November 26, 2021
WEE1 inhibition induces anti-tumor immunity by activating ERV and the dsRNA pathwayEnsong Guo, Rourou Xiao, Yifan Wu, et al.
Pageof 23